Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.
Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe S, Elliott R, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H. Xia XZ, et al. Among authors: khare sd. J Exp Med. 2000 Jul 3;192(1):137-43. doi: 10.1084/jem.192.1.137. J Exp Med. 2000. PMID: 10880535 Free PMC article.
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.
Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, Hawkins N, Kelley M, Chang D, Van G, Ross L, Delaney J, Wang L, Lacey D, Boyle WJ, Hsu H. Khare SD, et al. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3370-5. doi: 10.1073/pnas.97.7.3370. Proc Natl Acad Sci U S A. 2000. PMID: 10716715 Free PMC article.
The role of TALL-1 and APRIL in immune regulation.
Khare SD, Hsu H. Khare SD, et al. Trends Immunol. 2001 Feb;22(2):61-3. doi: 10.1016/s1471-4906(00)01843-3. Trends Immunol. 2001. PMID: 11286694 No abstract available.
T-cell co-stimulation through B7RP-1 and ICOS.
Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, Tafuri-Bladt A, Brankow D, Campbell P, Chang D, Chiu L, Dai T, Duncan G, Elliott GS, Hui A, McCabe SM, Scully S, Shahinian A, Shaklee CL, Van G, Mak TW, Senaldi G. Yoshinaga SK, et al. Among authors: khare sd. Nature. 1999 Dec 16;402(6763):827-32. doi: 10.1038/45582. Nature. 1999. PMID: 10617205
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells.
Rajasekaran N, Wang X, Ravindranathan S, Chin DJ, Tseng SY, Klakamp SL, Widmann K, Kapoor VN, Vexler V, Keegan P, Yao S, LaVallee T, Khare SD. Rajasekaran N, et al. Among authors: khare sd. Cancer Immunol Immunother. 2024 Feb 24;73(3):60. doi: 10.1007/s00262-024-03635-3. Cancer Immunol Immunother. 2024. PMID: 38400933 Free PMC article.
Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032].
Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Hernandez NE, et al. Among authors: khare sd. Heliyon. 2023 Jul 6;9(8):e17901. doi: 10.1016/j.heliyon.2023.e17901. eCollection 2023 Aug. Heliyon. 2023. PMID: 37701412 Free PMC article.
108 results